|
|
我国中药材标准与质量监管现状及对策研究
|
Abstract:
本文通过对我国中药材质量标准现状的分析，发现中药材质量标准存在我国药典中药材品种数量变动小，收载数量有限；部(局)颁中药材标准较少且年代久远，收载品种少；中药材地方标准散乱；中药材质量监管难度大的问题。提出增加部(局)颁标准中药材收载的品种数量，加大地方中药材标准的监管力度的具体对策。
Through the analysis of the current situation of the quality standards of Chinese herbal medicines in China, it is found that the quality standards of Chinese herbal medicines in the Chinese Pharmacopoeia have small changes in the number of varieties of Chinese herbal medicines, and the quantity collected is limited; There are few standards for traditional Chinese medicine issued by the Ministry (Bureau), which are old and have few varieties; The local standards of traditional Chinese medicine are scattered; It is difficult to supervise the quality of traditional Chinese medicine. It proposes specific countermeasures to increase the number of varieties of traditional Chinese medicine collected in the standards issued by the Ministry (Bureau) and strengthen the supervision of local standards of traditional Chinese medicine.
| [1] | 青子源, 马韶青, 郭丹丹. 中药材质量追溯监管的问题与对策[J]. 中国卫生法制, 2022, 30(4): 10-16. |
| [2] | 杨金铭, 徐文. 中药材质量监管的信息不对称研究[J]. 现代中药研究与实践, 2016, 30(5): 69-71. |
| [3] | 乔杨, 许亮, 谢明. 《中医药法》对我国中药材产业发展的影响探析[J]. 中国市场, 2021(23): 54-56. |
| [4] | 焦休良. 中药饮片质量监管问题与对策研究[D]: [硕士学位论文]. 绵阳: 西南科技大学, 2022. |
| [5] | 麻广霖, 赵宇新, 张伟. 学习贯彻新修订《药品管理法》强化药品标准的地位和作用[J]. 中国食品药品监管, 2020(1): 18-31. |
| [6] | 兰奋, 洪小栩, 宋宗华, 张伟. 《中国药典》2020年版基本概况和主要特点[J]. 中国药品标准, 2020, 21(3): 185-188. |
| [7] | 张鹏, 申明睿, 李浩, 翟为民, 倪龙, 郝博, 石上梅, 杨昭鹏, 兰奋, 张伟. 《中国药典》2020年版一部导读[J]. 中国药品标准, 2020, 21(3): 189-194. |
| [8] | 邓桥, 陆悦, 蒋红瑜, 李硕, 郭婷, 康绍博. 《中国药典》2020年版编制最新进展[N]. 中国医药报, 2019-10-23(003). |
| [9] | 赵宇新, 麻广霖, 于江泳. 关于完善地方药材标准管理的思考与建议[J]. 中国中药杂志, 2017, 42(13): 2619-2622. |
